Iteos Therapeutics Inc (ITOS)
$7.68 -$0.42 (-5.35%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$303.96M -
Day's Range
$7.51 - $7.89 -
Volume
451,763 -
52 Week Low / High
$7.54 - $18.75 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
ITOS's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $39.50
- Target Price
Company News
-
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones — Jan 8th, 2024
iTeos Therapeutics Inc. - TIGIT program clinical data readouts anticipated in 2024, including two Phase 2 trials assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - Adenosine portfolio clinical data readouts anticipated in second half of 2024, including inupadenant’s Phase 2...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$